Use of Recombinant Factor VIIa in Patients With Warfarin-Associated Intracranial Hemorrhage

Author： Brody David L.   Aiyagari Venkatesh   Shackleford Angela M.   Diringer Michael N.  

Publisher： Humana Press, Inc

ISSN： 1541-6933

Source： Neurocritical Care, Vol.2, Iss.3, 2005-06, pp. : 263-267

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Use of Recombinant Factor VIIa in Controlling Surgical Bleeding in Non-Haemophiliac Patients

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 32, Iss. 1, 2002-05 ,pp. : 41-46

Karger

Access to resources Recommend Favorite

Traumatic intracranial hemorrhage in patients using warfarin or clopidogrel

By  

Canadian Journal of Emergency Medicine, Vol. 16, Iss. 4, 2014-07 ,pp. : 327-329

Cambridge University Press

Access to resources Recommend Favorite

Activated Recombinant Human Coagulation Factor VII Therapy for Intracranial Hemorrhage in Patients with Hemophilia A or B with Inhibitors

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 28, Iss. 2, 1999-03 ,pp. : 93-98

Karger

Access to resources Recommend Favorite

Treatment of Bleeding in Patients with Platelet Disorders: Is There a Place for Recombinant Factor VIIa?

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 32, Iss. 1, 2002-05 ,pp. : 37-40

Karger

Access to resources Recommend Favorite

Improved survival of patients with warfarin‐associated intracerebral haemorrhage: a retrospective longitudinal population‐based study

By  

INTERNATIONAL JOURNAL OF STROKE, Vol. 10, Iss. 6, 2015-08 ,pp. : 876-881

John Wiley & Sons Inc

Access to resources Recommend Favorite